General Counsel Elham Dehbozorgi was quoted in the article “Conflict of Interest: How Five Firms Make Close Calls,” published by Managing IP. In the article, Elham commented on whether firms should advise both innovator and generic pharma companies, and whether competitors can be too close to advise. From the article:

“Elham Dehbozorgi, general counsel at Sterne Kessler in Washington DC, says conflicts checks are more difficult for IP firms because they have to worry about issues that other firms don’t.

For example, they have to review technology, which involves looking at clients’ competitors and products, and isn’t as straightforward as just checking the patent number, she says.”

© 2021 Euromoney Institutional Investor PLC.